Holen Sie sich die Stockscreener-App
123.71
1.63%
1.99
Handel nachbörslich:
124.00
0.29
+0.23%
Schlusskurs vom Vortag:
$121.72
Offen:
$122.3
24-Stunden-Volumen:
2.23M
Relative Volume:
1.30
Marktkapitalisierung:
$9.09B
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+2.03%
1M Leistung:
-2.28%
6M Leistung:
-12.71%
1J Leistung:
-7.60%
1-Tages-Spanne:
$121.51
$124.12
1-Wochen-Bereich:
$120.33
$124.26
52-Wochen-Spanne:
$107.43
$150.56
Ishares Biotechnology Etf Stock (IBB) Company Profile
Firmenname
Ishares Biotechnology Etf
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie IBB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IBB
Ishares Biotechnology Etf
|
123.71 | 9.09B | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
291.36 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
592.71 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
595.59 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
227.86 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
523.21 | 124.43B | 0 | 0 | 0 | 0.00 |
Ishares Biotechnology Etf Aktie (IBB) Neueste Nachrichten
Novavax Scores Key FDA Win, Shares Jump 19% As Sanofi Unlocks Milestone Payment - Benzinga
Nasdaq iShares Biotechnology ETF – IBB Elliott Wave technical analysis [Video] - FXStreet
Trump Orders FDA To Fast-Track US Drug Production As Tariff Threat Looms On Imported Medicines: Cites National Security ConcernsiShares Biotechnology ETF (NASDAQ:IBB), AbbVie (NYSE:ABBV) - Benzinga
Should You Invest in the VanEck Biotech ETF (BBH)? - Nasdaq
Nasdaq iShares Biotechnology ETF (IBB) Elliott Wave analysis [Video] - FXStreet
ETFs That Outperform the S&P 500: ARKK, VGT, IWF, XBI - Markets.com
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now? - Nasdaq
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now? - Nasdaq
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)? - Nasdaq
Exchange-Traded Funds, US Equities Advance After Midday Friday - TradingView
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Friday as Traders' Focus Turns to Quarterly Earnings - TradingView
Exchange-Traded Funds, US Equities Tumble After Midday - TradingView
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Thursday After US Tariff Pause - TradingView
Exchange-Traded Funds Mixed, US Equities Higher After Midday - TradingView
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Wednesday Amid China's Retaliatory Tariffs - TradingView
Should You Invest in the SPDR S&P Biotech ETF (XBI)? - Nasdaq
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Tuesday as Potential Japan-US Talks Lift Hopes - TradingView
Exchange-Traded Funds, US Equities Decline After Midday - TradingView
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Monday as Global Recession Concerns Intensify - TradingView
Should You Invest in the iShares Biotechnology ETF (IBB)? - Nasdaq
Exchange-Traded Funds, US Equities Plunge After Midday Friday - TradingView
7 Best ETFs to Buy Now | Investing | U.S. News - Money/ US News
Exchange-Traded Funds, US Equities Sink After Midday - TradingView
Exchange-Traded Funds, Equity Futures Edge Lower Pre-Bell Thursday Amid Heightened Global Trade War Concerns - TradingView
Head-To-Head Comparison: Invesco Trust for Investment Grade New York Municipals (NYSE:VTN) & iShares Biotechnology ETF (NASDAQ:IBB) - Defense World
Exchange-Traded Funds, US Equities Rise After Midday - TradingView
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Wednesday Ahead of US Tariffs Announcement - TradingView
Exchange-Traded Funds, Equity Futures Edge Lower Pre-Bell Tuesday Ahead of Economic Reports as Tariffs Announcement Looms - TradingView
Exchange-Traded Funds Lower, US Equities Mixed After Midday - TradingView
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Monday Amid Intensifying Trade War - TradingView
Exchange-Traded Funds, US Equities Slip After Midday Friday - TradingView
Exchange-Traded Funds, US Equities Lower After Midday - TradingView
Exchange-Traded Funds Decline, Equity Futures Mixed Pre-Bell Thursday Ahead of Slew of Economic Data - TradingView
Exchange-Traded Funds, US Equities Slide After Midday - TradingView
Exchange-Traded Funds Lower, Equity Futures Mixed Pre-Bell Wednesday as Investors Grapple With Tariff Uncertainty - TradingView
Exchange-Traded Funds, US Equities Mixed After Midday - TradingView
Exchange-Traded Funds, Equity Futures Edge Higher Pre-Bell Tuesday Amid Ongoing Tariff Confusion - TradingView
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Monday Ahead of Key Inflation Reports - TradingView
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Friday Amid Tariff Uncertainty, Lowered FedEx Outlook - TradingView
Exchange-Traded Funds, Equity Futures Lower Pre-Bell as Investors Digest Fed's Rate Decision - TradingView
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Wednesday Ahead of Fed Rate Decision - TradingView
Exchange-Traded Funds, US Equities Fall After Midday - TradingView
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Tuesday as Investors Exercise Caution Ahead of Fed Meeting - TradingView
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Monday as Recession Fears Heighten - TradingView
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Friday Amid Reduced Government Shutdown Risk - TradingView
Exchange-Traded Funds, US Equities Rise After Midday Friday - TradingView
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Thursday Ahead of Key Economic Reports - TradingView
Exchange-Traded Funds Rise, US Equities Mixed After Midday - TradingView
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Wednesday Ahead of Key Inflation Report - TradingView
Exchange-Traded Funds, US Equities Drop After Midday - TradingView
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Tuesday as Markets Recover Ahead of Economic Data - TradingView
Finanzdaten der Ishares Biotechnology Etf-Aktie (IBB)
Es liegen keine Finanzdaten für Ishares Biotechnology Etf (IBB) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.16%
0.13%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):